title: In vitro analysis and quantitative prediction of efavirenz inhibition of eight cytochrome P450 (CYP) enzymes: major effects on CYPs 2B6, 2C8, 2C9 and 2C19.
abstract: In order to quantitatively predict drug interactions associated with efavirenz-based anti-HIV therapy, we evaluated reversible and time-dependent inhibitions of efavirenz on eight cytochrome P450 (CYP) enzymes in vitro. The present study showed that efavirenz was a potent competitive inhibitor of CYP2B6 (average K(i) = 1.68 µM in HLMs and K(i) = 1.38 µM in expressed CYP2B6) and CYP2C8 (K(i) = 4.78 µM in pooled HLMs and K(i) = 4.80 µM in HLMs with CYP2C8*3/*3 genotype). Efavirenz was a moderate inhibitor of CYP2C9 (K(i) = 19.46 µM) and CYP2C19 (K(i) = 21.31 µM); and a weak inhibitor of CYP3A (K(i) = 40.33 µM). No appreciable inhibition was observed on CYP1A2, CYP2A6 or CYP2D6. No time-dependent inhibition of the CYPs by efavirenz was observed in this study. Quantitative predictions showed that single dose of efavirenz may substantially slow the elimination of drugs predominantly cleared by CYP2B6, CYP2C19 or by both enzymes and may also lower the area under the plasma concentration time curve (AUC) of active metabolites of some pro-drugs (e.g., clopidogrel and proguanil) by up to 30%. Depending on substrates, chronic administration of efavirenz may increase the AUC of CYP2C8 and CYP2C9 substrates about 3.5-4.4-fold and 1.7-2.0-fold at steady state.
authors: Indiana University School of Medicine, Indianapolis, IN, USA.
authors: Cong
authors: C
authors: Xu
authors: Zeruesenay
authors: Z
authors: Desta
mesh_terms: D000480:Alkynes; D044966:Anti-Retroviral Agents / Q000494:pharmacology*; D019540:Area Under Curve; D048588:Benzoxazines / Q000494:pharmacology*; D003521:Cyclopropanes; D065607:Cytochrome P-450 Enzyme Inhibitors; D004347:Drug Interactions; D006801:Humans; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D011355:Prodrugs / Q000378:metabolism; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology
chemical_list: D000480:Alkynes; D044966:Anti-Retroviral Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D065607:Cytochrome P-450 Enzyme Inhibitors; D011355:Prodrugs; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz
references: J Pharmacol Exp Ther. 2006 Jul;318(1):345-51
references: 16611850
references: Drug Metab Dispos. 2012 Jan;40(1):159-68
references: 22010218
references: J Clin Pharmacol. 2008 Jan;48(1):73-84
references: 18025525
references: Clin Pharmacol Ther. 1997 Sep;62(3):279-86
references: 9333103
references: Antimicrob Agents Chemother. 2011 Apr;55(4):1504-9
references: 21282425
references: Drug Metab Dispos. 2012 Jan;40(1):187-97
references: 22004687
references: J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):222-7
references: 19620877
references: Clin Pharmacol Ther. 2012 Mar;91(3):475-82
references: 22318618
references: Clin Infect Dis. 2005 Jul 15;41(2):e15-8
references: 15983905
references: Eur J Pharm Sci. 2010 Feb 19;39(4):213-8
references: 19961932
references: Antimicrob Agents Chemother. 2009 Feb;53(2):541-51
references: 19029318
references: J Pharmacol Exp Ther. 2007 Jan;320(1):72-80
references: 17041008
references: Drug Metab Dispos. 2009 Sep;37(9):1793-6
references: 19487252
references: Clin Pharmacol Ther. 2012 Mar;91(3):506-13
references: 22297387
references: J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):513-9
references: 18989234
references: Drug Metab Dispos. 2000 Oct;28(10):1222-30
references: 10997944
references: J Pharmacol Exp Ther. 2002 Feb;300(2):399-407
references: 11805197
references: Eur J Clin Pharmacol. 2001 Apr;57(1):31-6
references: 11372587
references: J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):307-12
references: 15980690
references: Antimicrob Agents Chemother. 2009 Jun;53(6):2346-53
references: 19223624
references: Drugs. 2010 Dec 3;70(17):2315-38
references: 21080746
references: N Engl J Med. 1999 Dec 16;341(25):1865-73
references: 10601505
references: Breast Cancer Res Treat. 2012 May;133(1):99-109
references: 21814747
references: Semin Thromb Hemost. 1999;25 Suppl 2:29-33
references: 10440420
references: AIDS. 2010 May 15;24(8):1223-6
references: 20299957
references: Blood. 2006 Oct 1;108(7):2244-7
references: 16772608
references: Biochem Pharmacol. 2011 Sep 15;82(6):681-91
references: 21726541
references: Nature. 1951 Dec 22;168(4288):1080
references: 14910643
references: Clin Pharmacol Ther. 2005 Dec;78(6):582-92
references: 16338274
references: Xenobiotica. 2002 Oct;32(10):863-78
references: 12419016
references: Curr Drug Metab. 2009 Nov;10(9):1009-47
references: 20214592
references: Drug Metab Dispos. 2012 Apr;40(4):717-25
references: 22232427
references: Clin Pharmacol Ther. 2005 May;77(5):341-52
references: 15900280
references: AIDS. 2009 Oct 23;23(16):2101-6
references: 19779319
references: J Clin Pharmacol. 2001 Jan;41(1):85-91
references: 11225565
references: Pharmacogenomics. 2009 Sep;10(9):1489-510
references: 19761371
references: J Clin Pharmacol. 2004 Nov;44(11):1273-81
references: 15496645
references: Pharmacogenet Genomics. 2009 Apr;19(4):300-9
references: 19238117
references: Drug Metab Dispos. 2010 Jan;38(1):92-9
references: 19812348
references: Clin Pharmacol Ther. 2003 Jan;73(1):20-30
references: 12545140
references: Clin Pharmacol Ther. 2007 Aug;82(2):197-203
references: 17361129
references: Clin Pharmacol Ther. 2012 Apr;91(4):673-84
references: 22398970
references: J Clin Pharmacol. 2006 Dec;46(12):1426-38
references: 17101742
references: Clin Infect Dis. 2007 Mar 15;44(6):889-91
references: 17304470
references: Drug Metab Dispos. 2010 Jul;38(7):1218-29
references: 20335270
references: Clin Pharmacol Ther. 2011 Oct;90(4):582-7
references: 21866098
references: Drug Metab Dispos. 2001 Feb;29(2):100-2
references: 11159797
references: J Pharmacol Exp Ther. 2003 Jul;306(1):287-300
references: 12676886
references: Drug Metab Dispos. 2000 Oct;28(10):1176-83
references: 10997936
references: Drug Metab Dispos. 2008 Nov;36(11):2355-70
references: 18669588
references: Drug Metab Dispos. 2008 Mar;36(3):523-8
references: 18048485
references: Clin Infect Dis. 2008 Jan 1;46(1):146-7
references: 18171231
references: Drug Metab Dispos. 2012 Jan;40(1):47-53
references: 21976621
references: Clin Pharmacol Ther. 2002 Jul;72(1):1-9
references: 12151999
references: Br J Clin Pharmacol. 2001 Mar;51(3):213-7
references: 11298066
references: Annu Rev Pharmacol Toxicol. 2005;45:477-94
references: 15822186
references: J Pharmacol Exp Ther. 2006 Jan;316(1):336-48
references: 16192315